(Q83533299)

English

The average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials

scientific article published on 07 March 2011

Statements

The average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit